LMR Partners LLP bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 25,485 shares of the company's stock, valued at approximately $1,616,000.
A number of other institutional investors have also modified their holdings of ACHC. Blue Trust Inc. increased its stake in Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company's stock valued at $36,000 after buying an additional 248 shares during the period. GAMMA Investing LLC increased its stake in shares of Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company's stock worth $42,000 after acquiring an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in Acadia Healthcare during the second quarter worth about $59,000. Covestor Ltd lifted its position in Acadia Healthcare by 834.4% in the third quarter. Covestor Ltd now owns 1,140 shares of the company's stock valued at $72,000 after purchasing an additional 1,018 shares during the period. Finally, DekaBank Deutsche Girozentrale purchased a new stake in Acadia Healthcare in the 3rd quarter valued at approximately $86,000.
Acadia Healthcare Price Performance
Shares of NASDAQ:ACHC traded down $0.04 on Tuesday, hitting $37.09. The company had a trading volume of 1,410,666 shares, compared to its average volume of 1,006,309. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The company has a market cap of $3.45 billion, a PE ratio of 12.17, a PEG ratio of 1.68 and a beta of 1.33. Acadia Healthcare Company, Inc. has a 52-week low of $36.50 and a 52-week high of $87.77. The business has a 50 day moving average of $57.27 and a 200 day moving average of $65.34.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. The company had revenue of $815.60 million for the quarter, compared to analysts' expectations of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the company earned $0.91 EPS. As a group, equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on ACHC shares. KeyCorp initiated coverage on Acadia Healthcare in a research note on Friday, October 11th. They set a "sector weight" rating for the company. StockNews.com upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research note on Thursday, November 14th. Cantor Fitzgerald restated a "neutral" rating and set a $90.00 target price on shares of Acadia Healthcare in a research report on Tuesday, October 1st. Barclays reduced their price target on shares of Acadia Healthcare from $83.00 to $76.00 and set an "overweight" rating for the company in a research report on Monday, September 30th. Finally, Royal Bank of Canada lowered their price target on Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating on the stock in a report on Monday. Five analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $83.33.
Read Our Latest Report on ACHC
Acadia Healthcare Company Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Further Reading
Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.